ATE178058T1 - Verfahren zur herstellung von gewissen biphenyltetrazolderivaten - Google Patents

Verfahren zur herstellung von gewissen biphenyltetrazolderivaten

Info

Publication number
ATE178058T1
ATE178058T1 AT92309968T AT92309968T ATE178058T1 AT E178058 T1 ATE178058 T1 AT E178058T1 AT 92309968 T AT92309968 T AT 92309968T AT 92309968 T AT92309968 T AT 92309968T AT E178058 T1 ATE178058 T1 AT E178058T1
Authority
AT
Austria
Prior art keywords
biphenyltetrazole
derivatives
producing certain
disclosed
producing
Prior art date
Application number
AT92309968T
Other languages
English (en)
Inventor
William V Murray
Ronald Russell
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of ATE178058T1 publication Critical patent/ATE178058T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92309968T 1991-11-01 1992-10-30 Verfahren zur herstellung von gewissen biphenyltetrazolderivaten ATE178058T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/786,666 US5252753A (en) 1991-11-01 1991-11-01 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Publications (1)

Publication Number Publication Date
ATE178058T1 true ATE178058T1 (de) 1999-04-15

Family

ID=25139265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92309968T ATE178058T1 (de) 1991-11-01 1992-10-30 Verfahren zur herstellung von gewissen biphenyltetrazolderivaten

Country Status (11)

Country Link
US (1) US5252753A (de)
EP (1) EP0540356B1 (de)
JP (1) JP3145813B2 (de)
AT (1) ATE178058T1 (de)
AU (1) AU651014B2 (de)
CA (1) CA2081847A1 (de)
DE (1) DE69228727T2 (de)
DK (1) DK0540356T3 (de)
ES (1) ES2130161T3 (de)
GR (1) GR3030330T3 (de)
SG (1) SG47012A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
PT788487E (pt) * 1994-10-27 2001-11-30 Novartis Ag Processo para a preparacao de tetrazoles
FR2753705B1 (fr) * 1996-09-20 1999-08-06 Procede pour la preparation de derives de 4-methyl-biphenyle
WO2002083127A1 (en) * 2001-04-09 2002-10-24 Tokai University Educational System Protein modification-inhibitory compositions
EP1571150A1 (de) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Prozess zur Herstellung von Tryptase Hemmstoffen
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
WO2006029056A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
KR20090102883A (ko) * 2004-09-02 2009-09-30 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
EP1749828A1 (de) 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012037298A1 (en) * 2010-09-17 2012-03-22 Glaxosmithkline Llc Fatty acid synthase inhibitors
EP2968439A2 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Zusammensetzungen zur behandlung von magen-darm-störungen
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
EP0412594B1 (de) * 1989-07-28 1996-01-03 Merck & Co. Inc. Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten
EP0443983B1 (de) * 1990-02-19 1996-02-28 Ciba-Geigy Ag Acylverbindungen
US5039814A (en) * 1990-05-02 1991-08-13 Merck & Co., Inc. Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl)benzenes
KR100196559B1 (ko) 1990-06-19 1999-06-15 기따사또 이찌로 안지오텐신ii 길항작용을 함유하는 피리딘 유도체
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process

Also Published As

Publication number Publication date
JP3145813B2 (ja) 2001-03-12
US5252753A (en) 1993-10-12
DK0540356T3 (da) 1999-10-11
AU2740492A (en) 1993-05-06
CA2081847A1 (en) 1993-05-02
SG47012A1 (en) 1998-03-20
GR3030330T3 (en) 1999-09-30
JPH05279350A (ja) 1993-10-26
EP0540356B1 (de) 1999-03-24
EP0540356A2 (de) 1993-05-05
EP0540356A3 (en) 1993-08-25
ES2130161T3 (es) 1999-07-01
AU651014B2 (en) 1994-07-07
DE69228727D1 (de) 1999-04-29
DE69228727T2 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
DE69228727D1 (de) Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten
DE69210347D1 (de) Verfahren zur Herstellung von Zwischenprodukten zur Verwendung in der Herstellung von Alkoxyiminoacetamide
ATE227292T1 (de) Herstellung von camptothecinderivaten durch intramolekulare cyclisierung
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
ATE207884T1 (de) Verfahren zur herstellung von aminobenzol- derivaten
ZA888448B (en) Novel compounds
DE69222012D1 (de) Verfahren zur Herstellung von Alpha-Ketoamidderivaten
ATE127809T1 (de) Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie.
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
ATE96464T1 (de) Verfahren zur herstellung von thiolen.
ATE221876T1 (de) Verfahren zur herstellung von zyklischen verbindungen
ATE272061T1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
DE69521012D1 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
DE69632919D1 (de) Verfahren zur herstellung von 2-chlor-5-chloromethyl-thiazol
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
ATE157971T1 (de) Verfahren zur herstellung von aminotriazin- derivaten
ATE335746T1 (de) Verfahren zur herstellung von epothilonen
ATE159246T1 (de) Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE127784T1 (de) Verfahren und zwischenprodukte für die herstellung von 2-hydroxy-3-sulfido-3- phenylpropansäuren.
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
DE69418802D1 (de) Verfahren zur Herstellung von N-Alkylacetamiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee